Diseases, Conditions, Syndromes

Research sheds light on a novel disease mechanism in chronic smokers

Research published in the journal Clinical Science suggests that an immune signalling protein called interleukin (IL)-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms ...

Medications

FDA bolsters warnings about class of antibiotics

(HealthDay)—The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including ...

page 4 from 7